カナダにおける薬物使用問題への対応に向けた薬物使用安定化モデル:提案された枠組み
Barbara Fornssler1, Maryellen Gibson2, Maggie Coupland3
1School of Public Health, University of Saskatchewan, Saskatoon, SK, Canada. barb.fornssler@usask.ca.
Canadian journal of public health = Revue canadienne de sante publique
|February 25, 2026
まとめ
カナダは深刻な薬物毒性危機に直面している。住宅、非犯罪化、規制された供給、治療を統合したエビデンスに基づいた薬物使用安定化フレームワークは、ハームリダクションの原則に基づいた前進への道を提供する。
科学分野:
- 公衆衛生
- 依存症医学
- 医療政策
背景:
- カナダは、広範な社会的危害を伴う重大な薬物毒性危機を経験している。
- 既存の政府のアプローチは、薬物使用問題の効果的な管理のために強化された戦略を必要としている。
研究 の 目的:
- 政策立案者が薬物毒性危機に対応するためのエビデンスに基づいたフレームワークを提案すること。
- 薬物使用の結果を改善するための分野横断的なアプローチを提唱すること。
主な方法:
- この解説では、薬物使用安定化フレームワークの概要を説明する。
- このフレームワークは、住宅、非犯罪化、規制された供給、治療といった主要な政策分野を統合する。
- このアプローチは、ハームリダクションの原則に基づいている。
主要な成果:
- 提案されたフレームワークは、地域社会と個人の成果のための包括的な戦略を提供する。
- 住宅、非犯罪化、供給、治療にわたる同時行動が不可欠である。
- このフレームワークの実施は、薬物使用問題への対応において大きな進歩をもたらすと期待される。
結論:
- カナダの薬物毒性危機を管理するためには、包括的で分野横断的なアプローチが不可欠である。
- 薬物使用安定化フレームワークは、政策立案者のための実行可能なモデルを提供する。
- 薬物使用問題に効果的に対処するためには、ハームリダクションの原則がすべての戦略の基礎とならなければならない。
さらに関連する動画
関連する概念動画
Substance Use Disorders Affecting Sleep
471
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
471
Community Based Intervention
532
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
532
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.3K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K
Stress and Mental Health
1.0K
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
1.0K
Drug Control Governance: Regulatory Bodies and Their Impact
612
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
612


